These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6340975)

  • 41. High dose salbutamol in chronic bronchitis: comparison of 400 micrograms, 1 mg, 1.6 mg, 2 mg and placebo delivered by Rotahaler.
    Jenkins SC; Moxham J
    Br J Dis Chest; 1987 Jul; 81(3):242-7. PubMed ID: 3311117
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The incidence of airflow obstruction in bronchial carcinoma, its relation to breathlessness, and response to bronchodilator therapy.
    Congleton J; Muers MF
    Respir Med; 1995 Apr; 89(4):291-6. PubMed ID: 7597269
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral diamorphine: lack of effect on dyspnoea and exercise tolerance in the "pink puffer" syndrome.
    Eiser N; Denman WT; West C; Luce P
    Eur Respir J; 1991 Sep; 4(8):926-31. PubMed ID: 1783082
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhaled formoterol dry powder in the treatment of patients with reversible obstructive airway disease. A 3-month, placebo-controlled comparison of the efficacy and safety of formoterol and salbutamol, followed by a 12-month trial with formoterol.
    Steffensen I; Faurschou P; Riska H; Rostrup J; Wegener T
    Allergy; 1995 Aug; 50(8):657-63. PubMed ID: 7503401
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Formoterol as inhalation powder in the treatment of patients with reversible obstructive lung diseases. A 3-month placebo-controlled comparison of the effects of formoterol and salbutamol, followed by a 12-month period with formoterol alone].
    Steffensen IE; Faurschou P
    Ugeskr Laeger; 1996 Dec; 158(49):7092-6. PubMed ID: 8999618
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-dose inhaled albuterol in severe chronic airflow limitation.
    Vathenen AS; Britton JR; Ebden P; Cookson JB; Wharrad HJ; Tattersfield AE
    Am Rev Respir Dis; 1988 Oct; 138(4):850-5. PubMed ID: 2462383
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of controlled-release salbutamol in predominantly non-reversible chronic airflow obstruction.
    Mohammed AF; Anderson K; Matusiewicz SP; Boyd G; Greening AP; Thomson NC
    Respir Med; 1991 Nov; 85(6):495-500. PubMed ID: 1775676
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of salbutamol on dynamic hyperinflation in chronic obstructive pulmonary disease patients.
    Tantucci C; Duguet A; Similowski T; Zelter M; Derenne JP; Milic-Emili J
    Eur Respir J; 1998 Oct; 12(4):799-804. PubMed ID: 9817148
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhaled salmeterol in the treatment of patients with moderate to severe reversible obstructive airways disease--a 3-month comparison of the efficacy and safety of twice-daily salmeterol (100 micrograms) with salmeterol (50 micrograms).
    Palmer JB; Stuart AM; Shepherd GL; Viskum K
    Respir Med; 1992 Sep; 86(5):409-17. PubMed ID: 1361068
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of outpatient nebulized vs metered dose inhaler terbutaline in chronic airflow obstruction.
    Mestitz H; Copland JM; McDonald CF
    Chest; 1989 Dec; 96(6):1237-40. PubMed ID: 2582827
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Addition of intravenous beta(2)-agonists to inhaled beta(2)-agonists for acute asthma.
    Travers AH; Milan SJ; Jones AP; Camargo CA; Rowe BH
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD010179. PubMed ID: 23235685
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lack of effect of inhaled morphine on exercise-induced breathlessness in chronic obstructive pulmonary disease.
    Masood AR; Reed JW; Thomas SH
    Thorax; 1995 Jun; 50(6):629-34. PubMed ID: 7638804
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nebulised salbutamol with and without ipratropium bromide in acute airflow obstruction.
    O'Driscoll BR; Taylor RJ; Horsley MG; Chambers DK; Bernstein A
    Lancet; 1989 Jun; 1(8652):1418-20. PubMed ID: 2567431
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of inhaled metaproterenol and orally-administered theophylline in patients with chronic airflow obstruction.
    Dullinger D; Kronenberg R; Niewoehner DE
    Chest; 1986 Feb; 89(2):171-3. PubMed ID: 3510820
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Theophylline plus salbutamol in chronic bronchial obstruction. The additive effects of combination therapy in comparison with salbutamol monotherapy].
    Bossert J; Träger E
    Fortschr Med; 1989 Apr; 107(11):255-8. PubMed ID: 2659475
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease.
    Papi A; Romagnoli M; Baraldo S; Braccioni F; Guzzinati I; Saetta M; Ciaccia A; Fabbri LM
    Am J Respir Crit Care Med; 2000 Nov; 162(5):1773-7. PubMed ID: 11069811
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Tsukino M; Mishima M; Izumi T
    Thorax; 1996 Jan; 51(1):48-53. PubMed ID: 8658369
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is oral theophylline effective in combination with both inhaled anticholinergic agent and inhaled beta 2-agonist in the treatment of stable COPD?
    Nishimura K; Koyama H; Ikeda A; Izumi T
    Chest; 1993 Jul; 104(1):179-84. PubMed ID: 8325065
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium : a 3-week, randomized, double-blind, within-patient, multicenter study.
    D'Urzo AD; De Salvo MC; Ramirez-Rivera A; Almeida J; Sichletidis L; Rapatz G; Kottakis J;
    Chest; 2001 May; 119(5):1347-56. PubMed ID: 11348938
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The protective effect of a beta 2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease.
    Bel EH; Zwinderman AH; Timmers MC; Dijkman JH; Sterk PJ
    Thorax; 1991 Jan; 46(1):9-14. PubMed ID: 1871705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.